Lung Neoplasms  >>  oxaliplatin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00087802 / 2004-005250-31: Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)

Completed
3
383
US
gemcitabine/Eloxatin (GEMOX), carboplatin/paclitaxel (CP)
Sanofi
Carcinoma, Non-Small-Cell Lung
05/07
 

Download Options